Literature DB >> 20547625

Accuracy of clinical diagnosis in tremulous parkinsonian patients: a blinded video study.

Nin P S Bajaj1, Vamsi Gontu, James Birchall, James Patterson, Donald G Grosset, Andrew J Lees.   

Abstract

BACKGROUND: This study examines the clinical accuracy of movement disorder specialists in distinguishing tremor dominant Parkinson's disease (TDPD) from other tremulous movement disorders by the use of standardised patient videos. PATIENTS AND METHODS: Two movement disorder specialists were asked to distinguish TDPD from patients with atypical tremor and dystonic tremor, who had no evidence of presynaptic dopaminergic deficit (subjects without evidence of dopaminergic deficit (SWEDDs)) according to (123)I-N-ω-fluoro-propyl- 2β-carbomethoxy-3β-(4-iodophenyl) nortropane ([(123)I] FP-CIT) single photon emission computed tomography (SPECT), by 'blinded' video analysis in 38 patients. A diagnosis of parkinsonism was made if the step 1 criteria of the Queen Square Brain Bank criteria for Parkinson's disease were fulfilled. The reviewer diagnosis was compared with the working clinical diagnosis drawn from the medical history, SPECT scan result, long term follow-up and in some cases the known response to dopaminergic medications. This comparison allowed a calculation for false positive and false negative rate of diagnosis of PD.
RESULTS: High false positive (17.4-26.1%) and negative (6.7-20%) rates were found for the diagnosis of PD. The diagnostic distinction of TDPD from dystonic tremor was reduced by the presence of dystonic features in treated and untreated PD patients.
CONCLUSION: Clinical distinction of TDPD from atypical tremor, monosymptomatic rest tremor and dystonic tremor can be difficult due to the presence of parkinsonian features in tremulous SWEDD patients. The diagnosis of bradykinesia was particularly challenging. This study highlights the difficulty of differentiation of some cases of SWEDD from PD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20547625     DOI: 10.1136/jnnp.2009.193391

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  28 in total

1.  Accuracy of subjective and objective handwriting assessment for differentiating Parkinson's disease from tremulous subjects without evidence of dopaminergic deficits (SWEDDs): an FP-CIT-validated study.

Authors:  N P S Bajaj; L Wang; V Gontu; D G Grosset; P G Bain
Journal:  J Neurol       Date:  2012-04-25       Impact factor: 4.849

2.  A smartphone camera reveals an 'invisible' Parkinsonian tremor: a potential pre-motor biomarker?

Authors:  Stefan Williams; Hui Fang; Jane Alty; Rami Qahwaji; Parisa Patel; Christopher D Graham
Journal:  J Neurol       Date:  2018-09-21       Impact factor: 4.849

3.  Longitudinal follow-up of SWEDD subjects in the PRECEPT Study.

Authors:  Kenneth Marek; John Seibyl; Shirley Eberly; David Oakes; Ira Shoulson; Anthony E Lang; Chris Hyson; Danna Jennings
Journal:  Neurology       Date:  2014-04-23       Impact factor: 9.910

4.  Impact of regional striatal dopaminergic function on kinematic parameters of Parkinson's disease.

Authors:  Myung Jun Lee; Sha-Lom Kim; Chul Hyoung Lyoo; J O Rinne; Myung-Sik Lee
Journal:  J Neural Transm (Vienna)       Date:  2014-08-22       Impact factor: 3.575

5.  Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease.

Authors:  Helen Ling; Luke A Massey; Andrew J Lees; Peter Brown; Brian L Day
Journal:  Brain       Date:  2012-03-06       Impact factor: 13.501

6.  Evaluation for Parkinsonian Bradykinesia by deep learning modeling of kinematic parameters.

Authors:  Dong Jun Park; Jun Woo Lee; Myung Jun Lee; Se Jin Ahn; Jiyoung Kim; Gyu Lee Kim; Young Jin Ra; Yu Na Cho; Weui Bong Jeong
Journal:  J Neural Transm (Vienna)       Date:  2021-01-28       Impact factor: 3.575

7.  Parkinson disease: Can dopamine transporter imaging define early PD?

Authors:  Angelo Antonini; Roberta Biundo
Journal:  Nat Rev Neurol       Date:  2014-07-08       Impact factor: 42.937

8.  Cardiac sympathetic denervation in Parkinson's disease patients with SWEDDs.

Authors:  Wooyoung Jang; Joong-Seok Kim; Jin Whan Cho; Young Hwan Kim; Ji Young Kim; Yun Young Choi; Hee-Tae Kim
Journal:  Neurol Sci       Date:  2012-11-24       Impact factor: 3.307

9.  Tamoxifen usage correlates with increased risk of Parkinson's disease in older women with breast cancer: a case-control study in Taiwan.

Authors:  Hsien-Feng Lin; Kuan-Fu Liao; Ching-Mei Chang; Cheng-Li Lin; Shih-Wei Lai
Journal:  Eur J Clin Pharmacol       Date:  2017-10-01       Impact factor: 2.953

10.  Computational approaches for understanding the diagnosis and treatment of Parkinson's disease.

Authors:  Stephen L Smith; Michael A Lones; Matthew Bedder; Jane E Alty; Jeremy Cosgrove; Richard J Maguire; Mary Elizabeth Pownall; Diana Ivanoiu; Camille Lyle; Amy Cording; Christopher J H Elliott
Journal:  IET Syst Biol       Date:  2015-12       Impact factor: 1.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.